Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using clinical data to determine vancomycin dosing parameters.

J K Birt1, M H Chandler

  • 1Division of Clinical Practice, College of Pharmacy, University of Kentucky, Lexington.

Therapeutic Drug Monitoring
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1997
Same author

Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors.

Pharmacotherapy·1997
Same author

T lymphocyte beta 2-adrenergic receptor function and density after acute myocardial infarction.

Pharmacotherapy·1997
Same author

Assay interaction between oxaprozin and phenytoin.

The Annals of pharmacotherapy·1997
Same author

Integrating pharmacokinetics into point-of-care information systems.

Clinical pharmacokinetics·1996
Same author

Comparison of creatinine clearance estimation methods in patients with trauma.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996

This study developed a new vancomycin dosing method using patient pharmacokinetic data and creatinine clearance. This individualized approach offers improved precision for vancomycin therapy.

Area of Science:

  • Pharmacokinetics
  • Clinical Pharmacy
  • Drug Dosing

Background:

  • Vancomycin is a critical antibiotic requiring precise dosing to ensure efficacy and minimize toxicity.
  • Standard dosing regimens may not be optimal for all patients due to inter-individual pharmacokinetic variability.
  • Accurate prediction of vancomycin pharmacokinetics is essential for therapeutic drug monitoring.

Purpose of the Study:

  • To evaluate serum concentrations and pharmacokinetic parameters of vancomycin in patients.
  • To develop and validate a novel vancomycin dosing method based on patient-specific pharmacokinetic data.
  • To compare the performance of the new dosing method against the established Matzke nomogram.

Main Methods:

  • Serum vancomycin concentrations and pharmacokinetic parameters (half-life, clearance, volume of distribution) were analyzed in 22 patients.

Related Experiment Videos

  • Geometric regression analysis identified a significant correlation between vancomycin clearance (Cl) and creatinine clearance (CrCl).
  • A new dosing equation was derived: Cl = (0.674)(CrCl) + 13.45, and its predictive performance was compared to the Matzke nomogram.

    • Main Results:

    • The study determined mean pharmacokinetic parameters for vancomycin: half-life (6.2 h), clearance (79.2 ml/min), and volume of distribution (0.54 L/kg).
    • A strong correlation (r=0.703) was found between vancomycin clearance and creatinine clearance (p<0.001).
    • The developed dosing method demonstrated less bias and greater precision for predicting half-life and volume of distribution compared to the Matzke nomogram.

    Conclusions:

    • A novel, individualized vancomycin dosing method based on patient pharmacokinetic parameters and creatinine clearance has been developed.
    • This method shows improved accuracy in predicting key pharmacokinetic variables, potentially leading to more optimized vancomycin therapy.
    • The findings support the use of institution-specific nomograms for personalized vancomycin dosing regimens.